×
About 40,910 results

ALLMedicine™ Bladder Cancer Center

Research & Reviews  19,349 results

Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-musc...
https://doi.org/10.1136/jitc-2020-001941
Journal for Immunotherapy of Cancer; Ji N, Mukherjee N et. al.

Mar 3rd, 2021 - Although intravesical BCG is the standard treatment of high-grade non-muscle invasive bladder cancer (NMIBC), response rates remain unsatisfactory. In preclinical models, rapamycin enhances BCG vaccine efficacy against tuberculosis and the killing...

The Impact of Previous Prostate Surgery on Surgical Outcomes for Patients Treated with ...
https://doi.org/10.1016/j.eururo.2021.02.029
European Urology; Rosiello G, Piazza P et. al.

Mar 3rd, 2021 - The feasibility and safety of robot-assisted radical cystectomy (RARC) may be undermined by unfavorable preoperative surgical characteristics such as previous prostate surgery (PPS). To compare perioperative outcomes for patients undergoing RARC w...

Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasi...
https://doi.org/10.1016/j.eururo.2021.02.021
European Urology; Bryan RT, Liu W et. al.

Mar 3rd, 2021 - Transurethral resection of bladder tumour (TURBT) is central to the diagnosis of muscle-invasive bladder cancer (MIBC). With the oncological safety of TURBT unknown, staging inaccuracies commonplace, and correct treatment of MIBC potentially delay...

Non-Bacterial Thrombotic Endocarditis as a Cause of Cryptogenic Stroke in Malignancy.
https://www.ncbi.nlm.nih.gov/pubmed/33648323
Rhode Island Medical Journal (2013); Ilyas S, Lang W et. al.

Mar 2nd, 2021 - Non-bacterial thrombotic endocarditis (NBTE) is characterized by the deposition of fibrin and platelet thrombi on previously undamaged heart valves in the absence of bloodstream infection. It is associated with chronic disease states and can prese...

MicroRNA‑34a‑5p serves as a tumor suppressor by regulating the cell motility of bladder...
https://doi.org/10.3892/or.2020.7910
Oncology Reports; Chou KY, Chang AC et. al.

Mar 2nd, 2021 - Bladder cancer (BC), a common urologic cancer, is the fifth most frequently diagnosed tumor worldwide. hsa‑miR‑34a displays antitumor activity in several types of cancer. However, the functional mechanisms underlying hsa‑miR‑34a in BC remains larg...

see more →

Guidelines  113 results

Moving on up: Maintenance therapy extends OS in bladder cancer
https://www.mdedge.com/hematology-oncology/article/222994/genitourinary-cancer/moving-maintenance-therapy-extends-os

May 27th, 2020 - Is maintenance therapy with an immune checkpoint inhibitor a good idea for patients with advanced bladder cancer who do not progress after initial chemotherapy?

New First-Line Standard in Metastatic Bladder Cancer
https://www.medpagetoday.com/meetingcoverage/asco/86731

May 27th, 2020 - Maintenance therapy with a PD-L1 immune checkpoint inhibitor improved overall survival (OS) for patients with advanced bladder cancer and stable disease following first-line chemotherapy, an interim analysis of a phase III trial found.

Report From the International Society of Urological Pathology (ISUP) Consultation Confe...
https://doi.org/10.1097/PAS.0000000000001453
The American Journal of Surgical Pathology; Warrick JI, Knowles MA et. al.

Feb 24th, 2020 - During the 2019 International Society of Urological Pathology Consultation Conference on Molecular Pathology of Urogenital Cancer, the Working Group on Bladder Cancer presented the current status and made recommendations on the diagnostic use of m...

Management of Muscle-invasive Bladder Cancer in the 2020s: Challenges and Perspectives.
https://doi.org/10.1016/j.euf.2020.01.007
European Urology Focus; Gakis G

Jan 28th, 2020 - Despite an increased use of neoadjuvant and adjuvant chemotherapy, the long-term survival rates after radical cystectomy or trimodal therapy (TMT) for muscle-invasive bladder cancer (MIBC) remain basically unchanged for decades. Detection and effe...

FDA approves pembrolizumab for BCG-unresponsive, high-risk non-muscle invasive bladder cancer
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-pembrolizumab-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer

Jan 7th, 2020 - The Food and Drug Administration approved pembrolizumab (KEYTRUDA, Merck & Co. Inc.) for the treatment of patients with Bacillus Calmette-Guerin (BCG)-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS)...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  20,469 results

Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-musc...
https://doi.org/10.1136/jitc-2020-001941
Journal for Immunotherapy of Cancer; Ji N, Mukherjee N et. al.

Mar 3rd, 2021 - Although intravesical BCG is the standard treatment of high-grade non-muscle invasive bladder cancer (NMIBC), response rates remain unsatisfactory. In preclinical models, rapamycin enhances BCG vaccine efficacy against tuberculosis and the killing...

The Impact of Previous Prostate Surgery on Surgical Outcomes for Patients Treated with ...
https://doi.org/10.1016/j.eururo.2021.02.029
European Urology; Rosiello G, Piazza P et. al.

Mar 3rd, 2021 - The feasibility and safety of robot-assisted radical cystectomy (RARC) may be undermined by unfavorable preoperative surgical characteristics such as previous prostate surgery (PPS). To compare perioperative outcomes for patients undergoing RARC w...

Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasi...
https://doi.org/10.1016/j.eururo.2021.02.021
European Urology; Bryan RT, Liu W et. al.

Mar 3rd, 2021 - Transurethral resection of bladder tumour (TURBT) is central to the diagnosis of muscle-invasive bladder cancer (MIBC). With the oncological safety of TURBT unknown, staging inaccuracies commonplace, and correct treatment of MIBC potentially delay...

Non-Bacterial Thrombotic Endocarditis as a Cause of Cryptogenic Stroke in Malignancy.
https://www.ncbi.nlm.nih.gov/pubmed/33648323
Rhode Island Medical Journal (2013); Ilyas S, Lang W et. al.

Mar 2nd, 2021 - Non-bacterial thrombotic endocarditis (NBTE) is characterized by the deposition of fibrin and platelet thrombi on previously undamaged heart valves in the absence of bloodstream infection. It is associated with chronic disease states and can prese...

MicroRNA‑34a‑5p serves as a tumor suppressor by regulating the cell motility of bladder...
https://doi.org/10.3892/or.2020.7910
Oncology Reports; Chou KY, Chang AC et. al.

Mar 2nd, 2021 - Bladder cancer (BC), a common urologic cancer, is the fifth most frequently diagnosed tumor worldwide. hsa‑miR‑34a displays antitumor activity in several types of cancer. However, the functional mechanisms underlying hsa‑miR‑34a in BC remains larg...

see more →

News  925 results

Bladder Cancer Indication Withdrawn for Durvalumab
https://www.medscape.com/viewarticle/946293

Feb 22nd, 2021 - After failing to improve overall survival in unresectable metastatic bladder cancer in a phase 3 trial, this indication will be withdrawn in the United States for the immunotherapy durvalumab (Imfinzi), AstraZeneca announced. The withdrawal does n...

Aspirin Linked to Reduced Bladder, Breast Cancer Mortality
https://www.medscape.com/viewarticle/945024

Jan 31st, 2021 - The use of low-dose aspirin among older people shows no effect in reducing the incidence of certain cancer types. However, the treatment — particularly with frequency of at least three times a week — is associated with reductions in mortality in b...

Companies Are Profiting From Health Data—Patients Should Too
https://www.medscape.com/viewarticle/944734

Jan 26th, 2021 - My patient, a woman with metastatic bladder cancer who was about to move to a different part of the country, was perplexed: "Can't you just give me my records on a flash drive?" Unfortunately it wasn't that easy. Forms needed to be routed through ...

Fast Five Quiz: Bladder Cancer Presentation and Diagnosis
https://reference.medscape.com/viewarticle/919963

Dec 28th, 2020 - Bladder cancer, a common urologic cancer, has the highest recurrence rate of any cancer. Globally, approximately 550,000 new cases of bladder cancer are diagnosed and nearly 200,000 deaths from bladder cancer occur each year. Whereas non–muscle-in...

Pre-COVID PHE Statistics Show Improving Cancer Survival Rates
https://www.staging.medscape.com/viewarticle/940661

Nov 9th, 2020 - Public Health England (PHE) has published new statistics which show improved survival in most cancers. The data cover a pre-pandemic period so the impact of recent delays in diagnosis and treatment won't be known for some time. The new figures sho...

see more →

Patient Education  43 results see all →